Alleviant Medical

Alleviant Medical is a medical device company based in Austin, Texas, founded in 2017.

The company focuses on developing minimally invasive therapies for chronic heart failure, specifically through its Alleviant System, a no-implant interatrial shunt system designed to relieve pressure in the left atrium. This innovative device aims to provide symptom relief for patients suffering from congestive heart failure, including those with preserved ejection fraction. Currently in the clinical stage, Alleviant Medical is conducting global pivotal trials to validate the benefits of its system. The company has received FDA Breakthrough Device Designation and IDE approval for its investigational device, which is not yet commercially available. With approximately $189 million in funding and a dedicated team of around 38 employees, Alleviant Medical is committed to addressing the unmet needs of patients with heart failure through its advanced interventional therapies.